Not provided
Not provided
Not provided
Not provided
Vendor equipment agreement expired
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will assess the effects of the Erigo applied as part of the early mobilization program in the Trauma ICU at the University of Kentucky. It is our hypothesis, that with the Erigo, critically ill patients will tolerate verticalization and mobilization earlier and safely resulting in improved outcomes measured by increased mobility and strength on ICU discharge, decreased requirements for mechanical ventilation, reduced complication rates and decreased ICU and hospital LOS.
The "Erigo" by Hocoma is a combination of tilt table with a robotic stepper device allowing for cyclic leg loading. Erigo now also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It allows for protected gradual verticalization and mobilization based on patient tolerance and progress. It has been shown to improve orthostatic tolerance, cerebral blood flow and muscle strength.
Prospective Randomized Controlled Trial will compare two groups. The patients that meet inclusion criteria will be randomized into either the treatment group or a control group. General ICU mobility guidelines consist of scaled activity related to the patients' stability. The control group will get the general ICU mobility treatments and the treatment group will have one mobility treatment replaced with the Erigo treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Erigo Pro plus standard Physical Therapy | Experimental | The Erigo device therapy is a combination of tilt table with robotic stepper device allowing for cyclic leg loading. It also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It will be used once a day to replace one of the standard PT therapies. The exercise mimics walking beyond what regular range of motion provides. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. |
|
| Standard Physical Therapy | Active Comparator | Patients will have 3 standard Physcial Therapy session. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Erigo Pro | Device | Verticalization table with two integrated robotic devices for leg movement and cyclic loading |
|
| Measure | Description | Time Frame |
|---|---|---|
| Orthostatic Tolerance During Verticalization | Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from lying down to standing. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial verticalization after injury and at each treatment session there after until they achieve ambulation (the ability to move without assistance). Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from lying to standing. | Up to one year |
| Orthostatic Tolerance During Ambulation | Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from standing to full ambulation. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial unassisted standing and then during each treatment session there after until discharge. Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from standing to full ambulation. | Up to one year |
| Measure | Description | Time Frame |
|---|---|---|
| ICU Length of Stay | The duration of stay in the Trauma ICU will be measured and compared between groups. Data will be presented as mean number of days in the ICU. | Up to three months |
| Hospital Length of Stay |
Not provided
Inclusion Criteria: Admission to Trauma ICU
Exclusion Criteria:
Patients with the following conditions:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Andrew Bernard, MD | University of Kentucky | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40536 | United States |
This study did not gather data beyond one intervention before closing. This is not applicable.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Erigo Pro Plus Standard Physical Therapy | The Erigo device therapy is a combination of tilt table with robotic stepper device allowing for cyclic leg loading. It also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It will be used once a day to replace one of the standard PT therapies. The exercise mimics walking beyond what regular range of motion provides. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Erigo Pro: Verticalization table with two integrated robotic devices for leg movement and cyclic loading |
| FG001 | Standard Physical Therapy | Patients will have 3 standard Physcial Therapy session. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Standard Physical Therapy: Patients receive standard physical therapy. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Erigo Pro Plus Standard Physical Therapy | The Erigo device therapy is a combination of tilt table with robotic stepper device allowing for cyclic leg loading. It also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It will be used once a day to replace one of the standard PT therapies. The exercise mimics walking beyond what regular range of motion provides. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Erigo Pro: Verticalization table with two integrated robotic devices for leg movement and cyclic loading |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Orthostatic Tolerance During Verticalization | Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from lying down to standing. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial verticalization after injury and at each treatment session there after until they achieve ambulation (the ability to move without assistance). Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from lying to standing. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
Adverse events were collected during hospitalization, up to one year.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Erigo Pro Plus Standard Physical Therapy | The Erigo device therapy is a combination of tilt table with robotic stepper device allowing for cyclic leg loading. It also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It will be used once a day to replace one of the standard PT therapies. The exercise mimics walking beyond what regular range of motion provides. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Erigo Pro: Verticalization table with two integrated robotic devices for leg movement and cyclic loading |
Not provided
Not provided
Study was terminated by the device manufacturer prior to any subject completing the intervention
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Lisa Fryman | University of Kentucky | 859 323 2060 | lisa.fryman@uky.edu |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Standard Physical Therapy | Other | Patients receive standard physical therapy. |
|
The duration of hospitalization will be measured and compared between groups. Data will be presented as mean number of days the participant is hospitalized.
| Up to one year |
| Incidence of Pneumonia While Hospitalized | Incidence of pneumonia while hospitalized will be determined by clinical symptoms to include temperature >100.8 degrees F, WBC>12,000 WBC/mm3 , PaO2/Fio2 ratio < 300 mmHg, positive respiratory culture for organisms and chest x-ray indicative of pneumonia. Total incidence will be compared between groups and presented as a total count of pneumonia diagnoses per group. | Up to one year |
| Incidence of Urinary Tract Infections While Hospitalized | Incidence of urinary tract infection during hospitalization will be determined by clinical symptoms to include temperature of > 100.8 degrees F, WBC> 12000 WBC/MM3, patient complaints of pain, positive urine culture. Total incidence will be compared between groups and presented as a total count of urinary tract infection diagnoses per group. | Up to one year |
| Incidence of Deep Vein Thrombosis (DVT) | Incidence of DVT with be determined based on clinical symptoms to include pain and positive duplex ultrasound or other diagnostic tool | Up to one year |
| Incidence of Pressure Ulcers | Incidence of pressure ulcers determined by physical observation. Total incidence will be compared between groups and presented as a total count of pressure ulcer diagnoses per group. | Up to one year |
| Incidence of Physical Instability | Incidence of physical instability with be calculated as the number of falls per participant while hospitalized. Data will be presented as the number of falls per participant per group. | Up to one year |
| Incidence of Catheter Disruption | Incidence of unplanned removal/displacement of lines/tubes/catheters. Data will be presented as the number of disruptions per participant per group. | Up to one year |
| Measure of Physical Capacity | Kansas University Hospital Physical Therapy Acute Care Functional Outcome Tool will be utilized to assess the participant's overall physical function prior to discharge. . Total score: 0 - 32, usually divided by 25%, 50%, >75% (minimum, moderate, maximum functionality). The higher the score, the great physical function the participant has. | At discharge (up to 1 year) |
| Measure of Muscle Power | The Muscle Research Council Muscle Scale will be used to determine actual muscle power generation vs the anticipated power generation prior to discharge. Total score: 0 - 5, 5 is normal muscle function. Data are presented as units on a scale. | Up to one year |
| Fall Risk | Participant fall risk will be determined prior to discharge using the Berg Balance Scale to assess impairment of balance function through the completion of several functional tasks. The data are presented as units on a scale. The higher the number the lower the fall risk. | Up to one year |
| Assessment of Participant Mobility | The ICU Mobility Scale ranks a participant's mobility on a scale of 0-32, were a score of zero is a completely non-mobile individual and a score of 32 is a fully ambulatory individual. Data will be collected at the time of discharge. The data are presented as units on a scale. | Up to one year |
| Independent Ambulation | The number of hospital days required for the participant to regain independent ambulation (the ability to walk 5 meters unassisted) with be measured and presented as total days. | Up to one year |
| Mid-leg Muscle Circumference | Mid-leg muscle circumference will be measure using a metric tape measure at hospital admission and again just prior to discharge. Data will be presented as the change in muscle circumference (cm) over time. | Up to one year |
| Number of Patients Discharged From Hospital to Home | The number of participants discharged to their home will be counted and presented as a percentage of the total participants in that arm. | Up to one year |
| Number of Patients Discharged From Hospital to Skilled Nursing Facility | The number of participants discharged to a skilled nursing home will be counted and presented as a percentage of the total participants in that arm. | Up to one year |
| Number of Patients Discharged From Hospital to a Long Term Care Facility | The number of participants discharged to a long term care facility will be counted and presented as a percentage of the total participants in that arm. | Up to one year |
| Number of Patients Discharged From Hospital to an Acute Rehabilitation Facility | The number of participants discharged to am acute rehabilitation facility will be counted and presented as a percentage of the total participants in that arm. | Up to one year |
| BG001 | Standard Physical Therapy | Patients will have 3 standard Physcial Therapy session. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Standard Physical Therapy: Patients receive standard physical therapy. |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
The Erigo device therapy is a combination of tilt table with robotic stepper device allowing for cyclic leg loading. It also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It will be used once a day to replace one of the standard PT therapies. The exercise mimics walking beyond what regular range of motion provides. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements.
Erigo Pro: Verticalization table with two integrated robotic devices for leg movement and cyclic loading
| OG001 | Standard Physical Therapy | Patients will have 3 standard Physcial Therapy session. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Standard Physical Therapy: Patients receive standard physical therapy. |
|
| Primary | Orthostatic Tolerance During Ambulation | Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from standing to full ambulation. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial unassisted standing and then during each treatment session there after until discharge. Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from standing to full ambulation. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | ICU Length of Stay | The duration of stay in the Trauma ICU will be measured and compared between groups. Data will be presented as mean number of days in the ICU. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to three months |
|
|
| Secondary | Hospital Length of Stay | The duration of hospitalization will be measured and compared between groups. Data will be presented as mean number of days the participant is hospitalized. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Incidence of Pneumonia While Hospitalized | Incidence of pneumonia while hospitalized will be determined by clinical symptoms to include temperature >100.8 degrees F, WBC>12,000 WBC/mm3 , PaO2/Fio2 ratio < 300 mmHg, positive respiratory culture for organisms and chest x-ray indicative of pneumonia. Total incidence will be compared between groups and presented as a total count of pneumonia diagnoses per group. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Incidence of Urinary Tract Infections While Hospitalized | Incidence of urinary tract infection during hospitalization will be determined by clinical symptoms to include temperature of > 100.8 degrees F, WBC> 12000 WBC/MM3, patient complaints of pain, positive urine culture. Total incidence will be compared between groups and presented as a total count of urinary tract infection diagnoses per group. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Incidence of Deep Vein Thrombosis (DVT) | Incidence of DVT with be determined based on clinical symptoms to include pain and positive duplex ultrasound or other diagnostic tool | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Incidence of Pressure Ulcers | Incidence of pressure ulcers determined by physical observation. Total incidence will be compared between groups and presented as a total count of pressure ulcer diagnoses per group. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Incidence of Physical Instability | Incidence of physical instability with be calculated as the number of falls per participant while hospitalized. Data will be presented as the number of falls per participant per group. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Incidence of Catheter Disruption | Incidence of unplanned removal/displacement of lines/tubes/catheters. Data will be presented as the number of disruptions per participant per group. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Measure of Physical Capacity | Kansas University Hospital Physical Therapy Acute Care Functional Outcome Tool will be utilized to assess the participant's overall physical function prior to discharge. . Total score: 0 - 32, usually divided by 25%, 50%, >75% (minimum, moderate, maximum functionality). The higher the score, the great physical function the participant has. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | At discharge (up to 1 year) |
|
|
| Secondary | Measure of Muscle Power | The Muscle Research Council Muscle Scale will be used to determine actual muscle power generation vs the anticipated power generation prior to discharge. Total score: 0 - 5, 5 is normal muscle function. Data are presented as units on a scale. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Fall Risk | Participant fall risk will be determined prior to discharge using the Berg Balance Scale to assess impairment of balance function through the completion of several functional tasks. The data are presented as units on a scale. The higher the number the lower the fall risk. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Assessment of Participant Mobility | The ICU Mobility Scale ranks a participant's mobility on a scale of 0-32, were a score of zero is a completely non-mobile individual and a score of 32 is a fully ambulatory individual. Data will be collected at the time of discharge. The data are presented as units on a scale. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Independent Ambulation | The number of hospital days required for the participant to regain independent ambulation (the ability to walk 5 meters unassisted) with be measured and presented as total days. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Mid-leg Muscle Circumference | Mid-leg muscle circumference will be measure using a metric tape measure at hospital admission and again just prior to discharge. Data will be presented as the change in muscle circumference (cm) over time. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Number of Patients Discharged From Hospital to Home | The number of participants discharged to their home will be counted and presented as a percentage of the total participants in that arm. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Number of Patients Discharged From Hospital to Skilled Nursing Facility | The number of participants discharged to a skilled nursing home will be counted and presented as a percentage of the total participants in that arm. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Number of Patients Discharged From Hospital to a Long Term Care Facility | The number of participants discharged to a long term care facility will be counted and presented as a percentage of the total participants in that arm. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| Secondary | Number of Patients Discharged From Hospital to an Acute Rehabilitation Facility | The number of participants discharged to am acute rehabilitation facility will be counted and presented as a percentage of the total participants in that arm. | ERIGO Pro manufacture requested the device be returned before any subject completed the protocol | Posted | Up to one year |
|
|
| 0 |
| 1 |
| 0 |
| 1 |
| 0 |
| 1 |
| EG001 | Standard Physical Therapy | Patients will have 3 standard Physcial Therapy session. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Standard Physical Therapy: Patients receive standard physical therapy. | 0 | 0 | 0 | 0 | 0 | 0 |
Not provided
Not provided